033270 — Korea United Pharm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for Korea United Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	30,916	26,613	28,649	45,275	48,262
Depreciation
Amortisation
Non-Cash Items	5,769	12,537	7,874	14,789	8,472
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5,559	-10,440	174	-5,271	-17,059
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	38,154	36,962	44,085	63,782	49,770
Capital Expenditures	-19,759	-12,546	-12,789	-24,207	-31,309
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-213	-21,181	-4,909	-63,695	-24,222
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-19,972	-33,727	-17,698	-87,902	-55,531
Financing Cash Flow Items	-47.6	-30.5	-73.5	560	375
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,720	-1,782	-8,197	-10,586	2,546
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	15,694	477	20,348	-33,933	-2,982